NCT03318393View on ClinicalTrials.gov

Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 25, 2018

Primary Completion Date

October 8, 2021

Study Completion Date

October 8, 2021

Conditions
Extracorporeal Membrane Oxygenation ComplicationPediatric ALLAnticoagulants
Interventions
DRUG

Bivalirudin

Continuous infusion

DRUG

Unfractionated heparin

Continuous infusion

Trial Locations (1)

75235

Children's Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03318393 - Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO | Biotech Hunter | Biotech Hunter